Graham Capital Management, L.P. Mereo Biopharma Group PLC Transaction History
Graham Capital Management, L.P.
- $5.17 Billion
- Q2 2025
A detailed history of Graham Capital Management, L.P. transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Graham Capital Management, L.P. holds 21,176 shares of MREO stock, worth $46,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,176
Previous 49,418
57.15%
Holding current value
$46,375
Previous $111,000
48.65%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MREO
# of Institutions
99Shares Held
98.2MCall Options Held
2.28MPut Options Held
761K-
Janus Henderson Group PLC London, X017.7MShares$38.7 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$33.5 Million0.96% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.44MShares$20.7 Million1.35% of portfolio
-
Mangrove Partners New York, NY8.64MShares$18.9 Million3.39% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.71MShares$14.7 Million0.42% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $274M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...